Armata Pharmaceuticals Q1 EPS $(0.69) Misses $(0.31) Estimate, Sales $966.00K Miss $1.10M Estimate
Author: Benzinga Newsdesk | May 07, 2024 04:41pm
Armata Pharmaceuticals (AMEX:
ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.31) by 122.58 percent. This is a 72.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $966.00 thousand which missed the analyst consensus estimate of $1.10 million by 12.18 percent. This is a 21.36 percent increase over sales of $796.00 thousand the same period last year.
Posted In: ARMP